Everest Group (EG) News
NYSE: EGFinanceProperty-Casualty InsurersUSD
368.37-4.73 (-1.27%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
EG news summary
We found 3 recent headlines mentioning Everest Group (EG): 1 in the past week and 2 in the past 30 days, most often from Nasdaq, PR Newswire. For price context, EG is down 1.27% at $368.37. The most recent story, "Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development", was published by PR Newswire on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Everest Group headlines
- Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical DevelopmentLakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead, Cancer Vaccines at…PR Newswire
- EG Stock Trading at a Discount to Industry at 0.92X: Time to Hold?Everest Group's disciplined underwriting, specialty growth and expanding third-party capital support growth as softer catastrophe pricing poses risks.NasdaqEG, AEG, AIG, AIZ
- Everest Group Lags Industry, Trades at a Discount: Time to Hold?EG's disciplined underwriting, specialty growth and expanding third-party capital platform support profitability, despite softer reinsurance pricing.NasdaqEG, AEG, AIG, AIZ